ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high
$9.49
Daily low
$9.49
Price at open
$9.49
52 Week High
$13.14
52 Week Low
$8.37
Market cap
16.8B
Dividend yield
5.36%
Volume
1,408
Avg. volume
136,040
P/E ratio
50.67

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News

Details

Daily high
$9.49
Daily low
$9.49
Price at open
$9.49
52 Week High
$13.14
52 Week Low
$8.37
Market cap
16.8B
Dividend yield
5.36%
Volume
1,408
Avg. volume
136,040
P/E ratio
50.67